Ivancovsky Wajcman Dana, Byrne Christopher J, Dillon John F, Brennan Paul N, Villota-Rivas Marcela, Younossi Zobair M, Allen Alina M, Crespo Javier, Gerber Lynn H, Lazarus Jeffrey V
Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
The Global NASH Council, Washington, District of Columbia, USA.
Hepatology. 2024 Aug 15. doi: 10.1097/HEP.0000000000001058.
Metabolic dysfunction-associated steatotic liver disease management guidelines have been published worldwide; we aimed to summarize, categorize, and compare their lifestyle intervention recommendations.
We searched metabolic dysfunction-associated steatotic liver disease/NAFLD management guidelines published between January 1, 2013, and June 31, 2024, through databases including PubMed/MEDLINE, Cochrane, and CINAHL. In total, 35 qualifying guidelines were included in the final analysis. Guideline recommendations were categorized into 5 domains (ie, weight reduction goals, physical activity, nutrition, alcohol, and tobacco smoking) and were ranked based on how frequently they appeared. A recommendation was defined as widely adopted if recommended in ≥24 (≥66.6%) of the guidelines. These included increasing physical activity; reducing body weight by 7%-10% to improve steatohepatitis and/or fibrosis; restricting caloric intake; undertaking 150-300 or 75-150 minutes/week of moderate or vigorous-intensity physical activity, respectively; and decreasing consumption of commercially produced fructose. The least mentioned topics, in ≤9 of the guidelines, evaluated environmental determinants of health, mental health, referring patients for psychological or cognitive behavioral therapy, using digital health interventions, and assessing patients' social determinants of health.
Most guidelines recommend weight reduction through physical activity and improving nutrition, as these have proven positive effects on health outcomes when sustained. However, gaps regarding mental health and the social and environmental determinants of metabolic dysfunction-associated steatotic liver disease were found. To optimize behavioral modifications and treatment, we recommend carrying out studies that will provide further evidence on social support, environmental factors, and mental health, as well as further exploring digital health interventions.
代谢功能障碍相关脂肪性肝病管理指南已在全球发布;我们旨在总结、分类并比较其生活方式干预建议。
我们通过包括PubMed/MEDLINE、Cochrane和CINAHL在内的数据库,检索了2013年1月1日至2024年6月31日期间发布的代谢功能障碍相关脂肪性肝病/非酒精性脂肪性肝病管理指南。最终分析共纳入35项合格指南。指南建议被分为5个领域(即减重目标、体育活动、营养、酒精和吸烟),并根据其出现的频率进行排名。如果在≥24项(≥66.6%)指南中被推荐,则该建议被定义为广泛采用。这些建议包括增加体育活动;减轻体重7%-10%以改善脂肪性肝炎和/或肝纤维化;限制热量摄入;分别进行每周150-300分钟或75-150分钟的中等强度或高强度体育活动;以及减少商业生产的果糖摄入。在≤9项指南中提及最少的主题包括评估健康的环境决定因素、心理健康、将患者转介接受心理或认知行为治疗、使用数字健康干预措施以及评估患者的健康社会决定因素。
大多数指南建议通过体育活动和改善营养来减轻体重,因为持续进行这些措施已被证明对健康结果有积极影响。然而,发现了在心理健康以及代谢功能障碍相关脂肪性肝病的社会和环境决定因素方面存在差距。为了优化行为改变和治疗,我们建议开展研究,以提供关于社会支持、环境因素和心理健康的进一步证据,并进一步探索数字健康干预措施。